HSGX - Histogenics Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development15,63415,56621,57723,243
Selling General and Administrative10,2049,3848,5308,266
Non Recurring----
Others----
Total Operating Expenses25,83824,95030,10731,509
Operating Income or Loss-25,838-24,950-30,107-31,509
Income from Continuing Operations
Total Other Income/Expenses Net17,195-1,46413,899-515
Earnings Before Interest and Taxes-25,838-24,950-30,107-31,509
Interest Expense---60-133
Income Before Tax-8,643-26,414-16,208-32,024
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-8,643-26,414-16,208-32,024
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,643-26,414-16,208-32,024
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,522-22,499-13,863-32,024